IL22 and chronic rhinosinusitis with nasal polyps: Relevant studies have shown that the levels of IL‐22 and its receptor (IL‐22R1) in invasive inflammatory cells and epithelial cells of the nasal passages of patients with CRSwNP are significantly increased.